BioSupply Trends Quarterly logo
Search
Close this search box.

Intranasal Flu Vaccine Developed with Nanoparticles

Intranasal Flu vaccine

Researchers in a study funded by the National Institute of Allergy and Infectious Diseases and the National Institutes of Health have developed an influenza (flu) vaccine administered through the nose that has been constructed with nanoparticles and offers stronger protection.

Universal Flu Vaccines Advance from Concept to Clinical Trials

Photo of patient receiving an injection

“Scientists have identified components of the influenza virus that do not really change muchat all. The critical challenge is getting a vaccine to induce a response to those components.”
— Anthony Fauci, MD, Director, National Institute of Allergy and Infectious Diseases